Other forms of coccidioidomycosis
ICD-10 B42.8 is a billable code used to indicate a diagnosis of other forms of coccidioidomycosis.
Coccidioidomycosis, commonly known as Valley Fever, is a fungal infection caused by the Coccidioides species, primarily C. immitis and C. posadasii. This condition is endemic to certain regions, particularly the southwestern United States, parts of Mexico, and Central and South America. The infection can manifest in various forms, ranging from asymptomatic to severe pulmonary disease, and can disseminate to other organs, particularly in immunocompromised patients. Other forms of coccidioidomycosis may include extrapulmonary manifestations such as meningitis, skin lesions, and bone involvement. Diagnosis is typically made through clinical evaluation, serological tests, and imaging studies. Treatment often involves antifungal medications such as fluconazole or itraconazole, especially in cases of severe or disseminated disease. The management of coccidioidomycosis in immunocompromised patients is particularly challenging due to their increased risk of severe disease and complications. Regular monitoring and adjustment of antifungal therapy are crucial in these populations to prevent progression of the disease.
Detailed clinical notes including symptoms, diagnostic tests, and treatment plans.
Patients presenting with respiratory symptoms, fever, or disseminated disease.
Consideration of immunocompromised status and potential for atypical presentations.
Pulmonary function tests, imaging studies, and treatment response documentation.
Patients with chronic cough, chest pain, or abnormal imaging findings.
Need for thorough evaluation of lung involvement and potential for chronic pulmonary complications.
Used to confirm diagnosis in suspected cases of coccidioidomycosis.
Document the clinical rationale for testing and results.
Infectious disease specialists should ensure comprehensive evaluation.
Common symptoms include fever, cough, chest pain, fatigue, and in severe cases, skin lesions or neurological symptoms.
Treatment typically involves antifungal medications such as fluconazole or itraconazole, especially in cases of severe or disseminated disease.
